期刊文献+

不同方式鼓室内给药后豚鼠耳蜗外淋巴液中地塞米松代谢动力学特征 被引量:17

Dexamethasone pharmacokinetics in perilymph of guinea pig after different topical administrations
原文传递
导出
摘要 目的:分析不同方式鼓室内给药后豚鼠耳蜗外淋巴液中地塞米松(DEX)代谢动力学特征,为临床选择鼓室内给药方式提供实验依据。方法:采用浸满DEX溶液明胶海绵颗粒置于圆窗龛内和鼓室内灌注两种鼓室内给药方式,采集给药后1~6h豚鼠鼓阶外淋巴液,应用高效液相色谱仪分别检测其中的DEX浓度。结果:相同浓度(10g/L)的DEX溶液经明胶海绵圆窗龛给药后外淋巴液中的DEX浓度1h时最高,DEX生物半衰期t1/2为2.37h。鼓室内灌注给药后外淋巴液中的DEX浓度1h20min时最高,DEX生物半衰期为t1/2为2.26h。除1h20min、1h40min和2h外,两种方式鼓室内给药后外淋巴液中DEX的浓度相比差异均有统计学意义(均P<0.05)。结论:明胶海绵颗粒圆窗龛给药和鼓室内灌注给药两种方式鼓室内给药后DEX均能有效地经圆窗膜渗透进入外淋巴液,大部分时间明胶海绵颗粒圆窗龛给药外淋巴液中的DEX浓度高于鼓室内灌注给药。明胶海绵圆窗龛给药的生物半衰期较长。 Objective:To determine pharmacokinetics profiles of dexamethasone (DEX) in perilymph of guinea pig with different intratympanic administrations,and to provide experimental evidence for clinical choice about administration.Method:Two different topical administrations placing a granule gelfoam soaked with DEX(10 g/L) in the niche of round window of guinea pig and infusing tympanic bulb with DEX solution(10 g/L) were conducted. Perilymph of the scala tympani was sampled 1-6 h after administration.DEX in the samples was assayed with high-performance liquid chromatograghy.Result:The concentrations of DEX in perilymph after placing a granule gelfoam soaked with DEX in the niche of round window were significantly higher than that after intratympanic infusing.The half-life time of DEX after placing a granule gelfoam was longer.Conclusion:DEX could effectively penetrate round window membrane into perilymph after different intratympanic administrations, and the method of placing a granule gelfoam soaked with DEX in the niche of round window is more effective than that of intratympanic infusing.
出处 《临床耳鼻咽喉科杂志》 CSCD 北大核心 2005年第7期307-310,共4页 Journal of Clinical Otorhinolaryngology
基金 上海市科委基金资助项目(No:034119819)
关键词 地塞米松 鼓室内给药 耳蜗水管 药物代谢动力学 Dexamethasone Intratympanic Cochlear aqueduct Pharmacokinetics
  • 相关文献

参考文献7

  • 1苏纪平,Bachmann G,唐安洲,Zumegen C,Michel O,Wittekindt C.局部和全身给药后泼尼松龙在外淋巴液中的浓度分析[J].临床耳鼻咽喉科杂志,2003,17(10):615-617. 被引量:16
  • 2Goycoolea M V. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol,2001,121:437- 447. 被引量:1
  • 3Jackson L E, Silverstein H. Chemical perfusion of the inner ear. Otolaryngol Clin North Am, 2002,35: 639 -653. 被引量:1
  • 4Stone J H, Francis H W. Immune-mediated inner ear disease. Curr Opin Rheumatol,2000,12: 32- 40. 被引量:1
  • 5Chandrasekhar S S,Rubinstein R Y,Kwartler J A,et al.Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg, 2000, 122: 521 -528. 被引量:1
  • 6Parnes L S, Sun A H, Freeman D J. Corticosteroid pharmacokinetics in the inner ear fluids:an animal study followed by clinical application. Laryngoscope, 1999,109:1-17. 被引量:1
  • 7Rahman M U,Poe D S,Choi H K. Autoimmune vestibulo-cochlear disorders. Curr Opin Rheumatol, 2001,13:184-189. 被引量:1

二级参考文献6

  • 1Michel O, Jahns T, Joost-Enneking M, et al. The stennert antiphlogistic-rheologic infusion schema in treatment of cochleovestibular disorders. HNO, 2000, 48:182-188. 被引量:1
  • 2Lamm K, Arnold W. The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear Res, 1998, 115:149-161. 被引量:1
  • 3Rarey K E, Curtis L M. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg, 1996, 115:38-41. 被引量:1
  • 4Buttgereit F, Brand M D, Burmester G R. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol, 1999, 58:363-368. 被引量:1
  • 5Parnes L S, Sun A H, Freeman D J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope, 1999, 109:1-17. 被引量:1
  • 6孙爱华,LorneS.Parnes,DavidJ.Freeman,林顺涨,刘为平.不同用药途径地塞米松在内耳液中的分布[J].中华耳鼻咽喉科杂志,2001,36(1):62-63. 被引量:33

共引文献15

同被引文献155

引证文献17

二级引证文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部